| Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors ES Ver Hoeve, L Ali-Akbarian, SN Price, NM Lothfi, HA Hamann Supportive Care in Cancer 29, 349-358, 2021 | 61 | 2021 |
| Tobacco use assessment and treatment in cancer patients: a scoping review of oncology care clinician adherence to clinical practice guidelines in the US SN Price, JL Studts, HA Hamann The oncologist 24 (2), 229-238, 2019 | 46 | 2019 |
| Socioeconomic status and health JM Ruiz, P Steffen, CY Doyle, MA Flores, SN Price Handbook of health psychology, 290-302, 2018 | 27 | 2018 |
| The use of varenicline to treat nicotine dependence among patients with cancer S Price, B Hitsman, A Veluz‐Wilkins, S Blazekovic, TR Brubaker, F Leone, ... Psycho‐Oncology 26 (10), 1526-1534, 2017 | 26 | 2017 |
| Reliability and validity of cutaneous sarcoidosis outcome instruments among dermatologists, pulmonologists, and rheumatologists H Yeung, S Farber, BK Birnbaum, J Dunham, A Ogdie, KC Patterson, ... JAMA dermatology 151 (12), 1317-1322, 2015 | 19 | 2015 |
| Urgent need for novel investigations of treatments to quit e-cigarettes: findings from a systematic review AM Palmer, SN Price, MG Foster, BT Sanford, LM Fucito, BA Toll Cancer Prevention Research 15 (9), 569-580, 2022 | 14 | 2022 |
| Ethnic differences in survival among lung cancer patients: A systematic review SN Price, M Flores, HA Hamann, JM Ruiz JNCI Cancer Spectrum 5 (5), pkab062, 2021 | 12 | 2021 |
| Responsiveness to change and establishment of the minimal clinically important difference for the cutaneous sarcoidosis activity and morphology instrument MH Noe, JM Gelfand, JS Bryer, SN Price, MA Judson, M Rosenbach JAMA dermatology 156 (1), 98-99, 2020 | 11 | 2020 |
| Patient-level factors associated with oncology provider-delivered brief tobacco treatment among recently diagnosed cancer patients JM Neil, SN Price, ER Friedman, C Ponzani, JS Ostroff, A Muzikansky, ... Tobacco Use Insights 13, 1179173X20949270, 2020 | 10 | 2020 |
| Developing an ACT-based intervention to address lung cancer stigma: Stakeholder recommendations and feasibility testing in two NCI-designated cancer centers DM Kaplan, HA Hamann, SN Price, TJ Williamson, ES Ver Hoeve, ... Journal of psychosocial oncology 41 (1), 59-75, 2023 | 5 | 2023 |
| Gender and racial/ethnic differences in CVD risk: Behavioral and psychosocial risk and resilience JM Ruiz, CY Doyle, MA Flores, SN Price Gender Differences in the Pathogenesis and Management of Heart Disease, 165-190, 2018 | 5 | 2018 |
| Poor subjective sleep quality among patients with cancer and comorbid depression: An opportunity to inform screening and intervention SN Price, HA Hamann, L Halaby, JI Trejo, F Corella, KL Weihs Behavioral Sleep Medicine 21 (1), 45-60, 2023 | 4 | 2023 |
| Think again: Adaptive repetitive thought as a transdiagnostic treatment for individuals predisposed to repetitive thinking styles. AV Lawrence, A Alkozei, MS Irgens, MC Acevedo-Molina, SA Brener, ... Journal of Psychotherapy Integration 31 (2), 208, 2021 | 4 | 2021 |
| Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study SN Price, AM Palmer, LM Fucito, EM Graboyes, NL Baker, AM Rojewski, ... Cancer 129 (15), 2385-2394, 2023 | 3 | 2023 |
| Advocacy and stigma among patients with lung cancer SN Price, JS Ostroff, M Shen, AJ Thomas, SJC Lee, H Hamann ANNALS OF BEHAVIORAL MEDICINE 51, S935-S936, 2017 | 2 | 2017 |
| Collaborative depression care sensitive to the needs of underserved patients with cancer: Feasibility, acceptability and outcomes S Price, HA Hamann, L Halaby, J Trejo, FC Rogers, K Weihs Journal of Psychosocial Oncology 42 (1), 90-112, 2024 | 1 | 2024 |
| Coping with COVID-19 in patients with Lung Cancer ES Ver Hoeve, SN Price, TK Torres, HA Hamann, LL Garland Oncology Issues 37 (5), 52-60, 2022 | 1 | 2022 |
| A prospective comparison of cutaneous sarcoidosis disease response to immunomodulatory and immunosuppressive therapies P Sharma, JS Bryer, S Price, MH Noe, M Rosenbach Journal of the American Academy of Dermatology 82 (6), 1546-1548, 2020 | 1 | 2020 |
| Patterns of neurological adverse events among a retrospective cohort of patients receiving immune checkpoint inhibitors JC Hunting, AT Faucheux, SN Price, CA Elko, A Quattlebaum, C Bloomer, ... Immunotherapy, 2024 | | 2024 |
| Cardiovascular health assessment in routine cancer follow-up in community settings: survivor risk awareness and perspectives KE Weaver, EV Dressler, S Smith, CL Nightingale, HD Klepin, SC Lee, ... BMC cancer 24 (1), 158, 2024 | | 2024 |
